Recurrent Childhood Brain Tumor Active Not Recruiting Phase Trials for Sorafenib (DB00398)

IndicationStatusPhase
DBCOND0030415 (Recurrent Childhood Brain Tumor)Active Not RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02015728Selecting Patient-Specific Biologically Targeted Therapy for Pediatric Patients With Refractory Or Recurrent Brain TumorsTreatment